Current Clinical Trials

Meru Health: Turmeric Study *

Our study focuses on determining the feasibility of asking our patients to take a daily curcumin-with-black-pepper supplement and determining whether doing so is associated with a reduction in inflammation markers (high sensitivity c-reactive protein and interleukin-6) as well as mental health symptoms (depression, anxiety, etc.) without any associated harms. All participants will receive the 12-week Meru Health Program, with one group taking mailed turmeric supplements. 

Impact of a ketogenic diet on metabolic and psychiatric health in patients with schizophrenia or bipolar illness*

To initiate a low-carbohydrate, high-fat ketogenic dietary intervention among a small cohort of outpatients with either schizophrenia or bipolar illness and comorbid overweight/obesity currently taking psychotropic medications.


FDA Approved Medication to Reduce Binge Eating and/or Purging*

This study will demonstrate the efficacy of Qsymia versus placebo in treating bulimia nervosa and binge eating disorder.


Ketogenic diet for psychotic disorders

This randomised, controlled pilot study aims to investigate the feasibility of a Modified Ketogenic Diet intervention protocol in psychotic inpatients, and the potential impact of this intervention on psychotic symptoms, depressive and anxiety symptoms, and functioning in patients with psychotic symptoms / psychotic disorder.